Robert Davis New CEO At Merck
… Merck names Robert Davis as new CEO …

EXECUTIVE PROFILE: Merck’s New CEO Robert Davis

Present Merck CEO Kenneth Frazier is retiring in June

Globally known and respected, Merck chief executive officer Kenneth Frazier is retiring

Kenneth Frazier, CEO, Chairman of the Board, Merck
… Retiring Merck CEO and Chairman of the Board Kenneth Frazier …

Robert Davis’ career is a distinguished track record of success in the healthcare industry; he has all the attributes Merck needs as its next CEO

  • Merck, Executive Vice President and Chief Financial Officer
  • Baxter Healthcare (NYSE: BAX): Corporate Vice President and President, Medical Products
  • Eli Lilly and Company (NYSE: LLY): Director of Corporate Financial Planning
New Merck CEO Robert Davis
… New Merck CEO Robert Davis …

Rob’s diversified board experience widens his perspective

  • AdvaMed
  • Baxter International Foundation (NYSE: BAX)
  • C.R. Bard/Becton Dickinson (NYSE: BDX)
  • Duke Energy (NYSE: DUK)
  • Project Hope
  • Rush University Medical Center

Davis’ academic background aligns with the corporate and regulatory challenges of the global healthcare industry

Merck launched a major corporate transformation initiative early in 2020

  • Biosimilars
  • Older legacy products
  • Women’s Healthcare
  • Animal Health
  • Hospital
  • Oncology
  • Vaccines

New partnerships, product launches and acquisitions continued at Merck during the transformation

Merck enters 2021 as a new company with a new leader and a formidable competitive position

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Bare Sky Marketing — Healthcare Content Writing

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/